Skip to main content
. 2019 Aug 14;2019:1601072. doi: 10.1155/2019/1601072

Figure 3.

Figure 3

The overall survival curve of ESCC patients with different levels of T-CTLA-4, I-CTLA-4, and PLR. The Kaplan-Meier survival curve for patients with ESCC whose tumors were classified as either higher or lower level for T-CTLA-4, I-CTLA-4, and PLR, respectively. T-CTLA-4 (p = 0.453), I-CTLA-4 (p = 0.654), and PLR (p = 0.703) status did not demonstrate a significant relation with patient survival.